Your email has been successfully added to our mailing list.

×
0.00103808118887613 0.00103808118887613 0.00337376386384749 0.00267715675025957 -0.000109271704092281 -0.000628312298530345 0.000764901928645658 0.0077309730645249
Stock impact report

FDA accepts BLA from BeiGene/Novartis for tislelizumab for esophageal cancer [Seeking Alpha]

BeiGene, Ltd. - American Depositary Shares (BGNE)  More Company Research Source: Seeking Alpha
Last beigene, ltd. - american depositary shares earnings: 3/2 04:05 pm Check Earnings Report
PDF FDA accepts BLA from BeiGene/Novartis for tislelizumab for esophageal cancer [Read more]
Impact snapshot Event time: BGNE
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
BGNE alerts
from News Quantified
Opt-in for
BGNE alerts

from News Quantified
Opt-in for
BGNE alerts

from News Quantified